SynthesisClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis.

David Charles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.